James Peyer - 02 Mar 2022 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
02 Mar 2022
Net transactions value
+$3,850
Form type
4/A - Amendment
Filing time
10 Jun 2022, 14:18:16 UTC
Date Of Original Report
02 Mar 2022
Previous filing
01 Mar 2022
Next filing
01 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $3,850 +1,203 +0.02% $3.20 5,231,488 02 Mar 2022 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed solely to correct the number of shares beneficially owned following the transaction reported herein.
F2 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.